Through the 90-day period concluding February 07, 2026, Rhythm Pharmaceuticals's top three insider stakeholders include President And Ceo David P Meeker (239.02K shares), Chief Financial Officer Hunter C Smith (125.54K shares), Evp And Head Of International Yann Mazabraud (43.16K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| David P Meeker | President And Ceo | 239,016 | 03 Feb, 2026 |
| Hunter C Smith | Chief Financial Officer | 125,537 | 06 Feb, 2026 |
| Yann Mazabraud | Evp And Head Of International | 43,155 | 03 Feb, 2026 |
| Pamela J. Cramer | Chief Human Resources Officer | 29,376 | 03 Feb, 2026 |
| Jennifer Kayden Lee | Evp And Head Of North America | 19,233 | 03 Feb, 2026 |
| Joseph Shulman | Chief Technical Officer | 18,970 | 03 Feb, 2026 |
| Edward T Mathers | 12,771 | 23 Jun, 2025 | |
| William T. Roberts | Chief Accounting Officer | 7,872 | 31 Mar, 2023 |
| Alastair Garfield | Chief Scientific Officer | 7,763 | 03 Feb, 2026 |
| Camille L Bedrosian | 7,000 | 23 Jun, 2025 | |
| Stuart A Arbuckle | 7,000 | 23 Jun, 2025 | |
| Christophe Jean | 7,000 | 23 Jun, 2025 | |
| Lynn A. Tetrault | 7,000 | 23 Jun, 2025 | |
| David W J Mcgirr | 7,000 | 23 Jun, 2025 | |
| Jennifer L Good | 7,000 | 23 Jun, 2025 | |
| Christopher Paul German | Corporate Controller & Cao | 3,433 | 03 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Feb, 2026 | Hunter C Smith | Common Stock | D | 3,381 | $106.06 | 125,537 | D | S |
| 04 Feb, 2026 | Hunter C Smith | Common Stock | D | 1,500 | $104.74 | 130,665 | D | S |
| 04 Feb, 2026 | Hunter C Smith | Common Stock | D | 747 | $107.67 | 128,918 | D | S |
| 04 Feb, 2026 | Hunter C Smith | Common Stock | D | 1,000 | $106.60 | 129,665 | D | S |
| 01 Feb, 2026 | Christopher Paul German | Common Stock | D | 1,138 | $108.99 | 3,433 | D | F |
| 01 Feb, 2026 | Christopher Paul German | Common Stock | A | 3,613 | - | 4,571 | D | M |
| 01 Feb, 2026 | David P Meeker | Common Stock | A | 68,713 | - | 270,538 | D | M |
| 01 Feb, 2026 | David P Meeker | Common Stock | D | 31,522 | $108.99 | 239,016 | D | F |
| 01 Feb, 2026 | Hunter C Smith | Common Stock | A | 26,000 | - | 142,915 | D | M |
| 01 Feb, 2026 | Hunter C Smith | Common Stock | D | 10,750 | $108.99 | 132,165 | D | F |
| 01 Feb, 2026 | Yann Mazabraud | Common Stock | A | 5,500 | - | 43,155 | D | M |
| 01 Feb, 2026 | Jennifer Kayden Lee | Common Stock | D | 9,237 | $108.99 | 19,233 | D | F |
| 01 Feb, 2026 | Jennifer Kayden Lee | Common Stock | A | 22,612 | - | 28,470 | D | M |
| 01 Feb, 2026 | Pamela J. Cramer | Common Stock | D | 4,731 | $108.99 | 29,376 | D | F |
| 01 Feb, 2026 | Pamela J. Cramer | Common Stock | A | 13,293 | - | 34,107 | D | M |
| 01 Feb, 2026 | Joseph Shulman | Common Stock | D | 6,507 | $108.99 | 18,970 | D | F |
| 01 Feb, 2026 | Joseph Shulman | Common Stock | A | 16,968 | - | 25,477 | D | M |
| 01 Feb, 2026 | Alastair Garfield | Common Stock | D | 2,026 | $108.99 | 7,763 | D | F |
| 01 Feb, 2026 | Alastair Garfield | Common Stock | A | 6,663 | - | 9,789 | D | M |
| 11 Dec, 2025 | Pamela J. Cramer | Common Stock | D | 3,350 | $111.00 | 20,814 | D | S |